|
Native Antigen Inc
sars s1 his tag ![]() Sars S1 His Tag, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/SARS+Coronavirus+Spike+Glycoprotein+(S1)%2C+His-Tag+(HEK293)/pmc13612045-86-0-6 Average 91 stars, based on 1 article reviews
sars s1 his tag - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Sino Biological
murine anti sars cov 2 spike protein detection antibody ![]() Murine Anti Sars Cov 2 Spike Protein Detection Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/Human+coronavirus+spike+glycoprotein+Antibody%2C+Mouse+MAb/us12594292-210-21-30 Average 94 stars, based on 1 article reviews
murine anti sars cov 2 spike protein detection antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
mers s1 camel fc tag ![]() Mers S1 Camel Fc Tag, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/MERS+Coronavirus+Spike+Glycoprotein+(S1)%2C+Camel+Fc-Tag+(HEK293)/pmc13612045-89-0-7 Average 94 stars, based on 1 article reviews
mers s1 camel fc tag - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
sars cov 2 spike glycoprotein ![]() Sars Cov 2 Spike Glycoprotein, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/SARS-CoV-2+Stabilized+Spike+Glycoprotein+(Full-Length)%2C+His-Strep-Tag+(HEK293)/pmc13240347-366-24-27 Average 94 stars, based on 1 article reviews
sars cov 2 spike glycoprotein - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Addgene inc
full length sars cov 2 spike glycoprotein ![]() Full Length Sars Cov 2 Spike Glycoprotein, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/pDONR223+SARS-CoV-2+S+(Plasmid+%23149329)/pmc13000666-51-4-10 Average 93 stars, based on 1 article reviews
full length sars cov 2 spike glycoprotein - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Mimetics
spike trimer glycoproteins heparin mimetics ![]() Spike Trimer Glycoproteins Heparin Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/glycoproteins+heparin+mimetics+spike+trimer/pmc13023951-2-3-7 Average 86 stars, based on 1 article reviews
spike trimer glycoproteins heparin mimetics - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
omicron spike ![]() Omicron Spike, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/SARS-CoV-2+(B%2E1%2E1%2E529%2FOmicron)+Stabilized+Spike+Glycoprotein+(Trimeric)%2C+His-Strep-Tag+(HEK293)/pmc12574661-328-48-53 Average 94 stars, based on 1 article reviews
omicron spike - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cube Biotech GmbH
fullsequence sars cov 2 spike glycoprotein trimers ![]() Fullsequence Sars Cov 2 Spike Glycoprotein Trimers, supplied by Cube Biotech GmbH, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/SARS+COV-2+SPIKE+PROTEIN+-+LMNG/10__18103_slash_mra__v14i4__7470-40-0-13 Average 92 stars, based on 1 article reviews
fullsequence sars cov 2 spike glycoprotein trimers - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Sino Biological
mouse monoclonal anti sarscov 2 spike glycoprotein antibody ![]() Mouse Monoclonal Anti Sarscov 2 Spike Glycoprotein Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/SARS-CoV-2+Spike+Antibody%2C+Mouse+MAb/pm41444793-380-35-42 Average 93 stars, based on 1 article reviews
mouse monoclonal anti sarscov 2 spike glycoprotein antibody - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Sino Biological
mouse monoclonal anti sars cov 2 spike glycoprotein antibody ![]() Mouse Monoclonal Anti Sars Cov 2 Spike Glycoprotein Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spike+glycoprotein/Anti-SARS-COV-2+Spike/pm41444793-383-6-12 Average 96 stars, based on 1 article reviews
mouse monoclonal anti sars cov 2 spike glycoprotein antibody - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Total spike and nucleocapsid (N) binding antibodies (IgG) of cohort against various Beta-coronaviruses. Meso Scale Discovery (MSD) analysis was performed on n = 103 UK negative controls (negative), 517 rural forested region samples (Macenta), 66 and 94 samples from the urban areas of Coyah and Gueckedou and 51 UK COVID-19 convalescent samples (COVID-19). The responses to various antigens are displayed as follows: ( A ) SARS-CoV-2 spike; ( B ) SARS-CoV-2 RBD; ( C ) SARS-CoV-2 N; ( D ) SARS-CoV spike; ( E ) MERS-CoV spike. Data are shown as a calculated concentration using a known reference serum and a 4PL fit curve; dashed line represents our in-house cut-off between negative and positive and is determined as the mean of the negative population plus five SD. Mean with standard deviation (SD) is displayed. Statistical analysis used Kruskal–Wallis with multiple comparisons; all groups showed statistical significance vs. the negative group across all antigens tested. p = ≤ 0.001 (***) and p = ≤ 0.0001 (****).
Article Snippet:
Techniques: Binding Assay, Analysis, Concentration Assay, Standard Deviation
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: ELISA analysis of SARS-CoV, SARS-CoV-2 and MERS-CoV spike proteins. ELISA analysis was performed on 103 UK negative controls, 517 rural forested region samples (Macenta), 66 and 94 samples from the urban areas of Coyah (COY) and Gueckedou (GKD), and 18 COVID-19 convalescent samples (COVID-19). The response to various antigens is displayed as follows: ( A ) SARS-CoV spike, S1 only or RBD; ( B ) SARS-CoV-2 spike, S1 only or RBD; and ( C ) MERS-CoV spike, S1 only or RBD. Values are displayed as arbitrary units: a 3PL fit curve using an in-house standard was used to calculate values, and an AU of 1 would be equivalent activity to the standard. The dashed line represents the in-house cut-off value and is based on the mean of the negatives plus five SD. The mean and 95% CI are displayed. Statistical analysis used Kruskal–Wallis with multiple comparisons; significant differences to the negative group are shown. Where error bars are not present significance did not reach ≤ p = 0.05. p = ≤ 0.05 (*) and p = ≤ 0.0001 (****).
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay, Analysis, Activity Assay
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Correlation and spatial analysis of rural Guinean samples. ( A ) Geographical map of the republic of Guinea, showing the locations of Coyah and Gueckadou (black star) along with an insert of the Macenta region showing the location of individual villages. ( B ) Mean posterior estimate of probability of individuals belonging to the subgroup with elevated responses to SARS-CoV and MERS-CoV antigens. ( C ) Macenta village-level seroprevalence of responses to all assays used.
Article Snippet:
Techniques: Analysis
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Mapping antibody binding of MERS-CoV reactive samples using a linear peptide array. ( A ) We subjected nine samples to a linear peptide array: seven were reactive to either SARS-CoV, SARS-CoV-2 or MERS-CoV glycoprotein (blue) and two were unreactive by ELISA and were used as a negative control (black). Samples were sent for processing at PEPperPRINT and were assayed against a linear peptide array of 15 amino acids off-set by two amino acids and spanning the glycoproteins of SARS-CoV, SARS-CoV-2, MERS-CoV, HKU1, 229E, NL63 and OC43. Following acquisition, sample peptides with a mean sasa of greater than 30% were included in downstream analysis. ( B , C ) Mapping of antibody binding regions for JB122 and JB055 using PyMOL v2.5 (yellow = S1, blue = RBD, red = antibody binding site).
Article Snippet:
Techniques: Binding Assay, Peptide Microarray, Enzyme-linked Immunosorbent Assay, Negative Control, Analysis
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Source of antigens used in our in-house ELISA.
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Total spike and nucleocapsid (N) binding antibodies (IgG) of cohort against various Beta-coronaviruses. Meso Scale Discovery (MSD) analysis was performed on n = 103 UK negative controls (negative), 517 rural forested region samples (Macenta), 66 and 94 samples from the urban areas of Coyah and Gueckedou and 51 UK COVID-19 convalescent samples (COVID-19). The responses to various antigens are displayed as follows: ( A ) SARS-CoV-2 spike; ( B ) SARS-CoV-2 RBD; ( C ) SARS-CoV-2 N; ( D ) SARS-CoV spike; ( E ) MERS-CoV spike. Data are shown as a calculated concentration using a known reference serum and a 4PL fit curve; dashed line represents our in-house cut-off between negative and positive and is determined as the mean of the negative population plus five SD. Mean with standard deviation (SD) is displayed. Statistical analysis used Kruskal–Wallis with multiple comparisons; all groups showed statistical significance vs. the negative group across all antigens tested. p = ≤ 0.001 (***) and p = ≤ 0.0001 (****).
Article Snippet:
Techniques: Binding Assay, Analysis, Concentration Assay, Standard Deviation
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: ELISA analysis of SARS-CoV, SARS-CoV-2 and MERS-CoV spike proteins. ELISA analysis was performed on 103 UK negative controls, 517 rural forested region samples (Macenta), 66 and 94 samples from the urban areas of Coyah (COY) and Gueckedou (GKD), and 18 COVID-19 convalescent samples (COVID-19). The response to various antigens is displayed as follows: ( A ) SARS-CoV spike, S1 only or RBD; ( B ) SARS-CoV-2 spike, S1 only or RBD; and ( C ) MERS-CoV spike, S1 only or RBD. Values are displayed as arbitrary units: a 3PL fit curve using an in-house standard was used to calculate values, and an AU of 1 would be equivalent activity to the standard. The dashed line represents the in-house cut-off value and is based on the mean of the negatives plus five SD. The mean and 95% CI are displayed. Statistical analysis used Kruskal–Wallis with multiple comparisons; significant differences to the negative group are shown. Where error bars are not present significance did not reach ≤ p = 0.05. p = ≤ 0.05 (*) and p = ≤ 0.0001 (****).
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay, Analysis, Activity Assay
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Correlation and spatial analysis of rural Guinean samples. ( A ) Geographical map of the republic of Guinea, showing the locations of Coyah and Gueckadou (black star) along with an insert of the Macenta region showing the location of individual villages. ( B ) Mean posterior estimate of probability of individuals belonging to the subgroup with elevated responses to SARS-CoV and MERS-CoV antigens. ( C ) Macenta village-level seroprevalence of responses to all assays used.
Article Snippet:
Techniques: Analysis
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Mapping antibody binding of MERS-CoV reactive samples using a linear peptide array. ( A ) We subjected nine samples to a linear peptide array: seven were reactive to either SARS-CoV, SARS-CoV-2 or MERS-CoV glycoprotein (blue) and two were unreactive by ELISA and were used as a negative control (black). Samples were sent for processing at PEPperPRINT and were assayed against a linear peptide array of 15 amino acids off-set by two amino acids and spanning the glycoproteins of SARS-CoV, SARS-CoV-2, MERS-CoV, HKU1, 229E, NL63 and OC43. Following acquisition, sample peptides with a mean sasa of greater than 30% were included in downstream analysis. ( B , C ) Mapping of antibody binding regions for JB122 and JB055 using PyMOL v2.5 (yellow = S1, blue = RBD, red = antibody binding site).
Article Snippet:
Techniques: Binding Assay, Peptide Microarray, Enzyme-linked Immunosorbent Assay, Negative Control, Analysis
Journal: Viruses
Article Title: Identification of Serum Antibodies Cross-Reactive with Pathogenic Betacoronavirus Amongst Rural Communities Within the Forested Region of the Republic of Guinea
doi: 10.3390/v18090989
Figure Lengend Snippet: Source of antigens used in our in-house ELISA.
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay
Journal: Aging Cell
Article Title: Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults—A Pilot Study
doi: 10.1111/acel.70545
Figure Lengend Snippet: Enhanced vaccine responses observed with Spermidine supplementation. (A) ACE2 inhibition (%) fold change from neutralisation antibody assay in placebo and spermidine groups at 2 weeks, against SARS‐CoV‐2 variants: Wuhan, P.2 (Zeta), B.1.1.7 (Alpha), B.1.617 (India), B.1.351 (Beta), B.1.526 (New York), B.1.617.2 (Delta), B 1.617.1 (Kappa), B.1.617.3 (India), P.1(Gamma). Placebo (grey) and Spd group (orange). (B) Anti‐spike IgG fold change at (left panel) 2 weeks, (middle panel) 13 weeks, and (right panel) 37 weeks post spermidine. Placebo (grey) and Spd group (orange). (C) Anti‐spike IgG intensity (ELISA) at day 0/baseline for the placebo group vaccine responders (R, grey, n = 16), placebo vaccine non‐responders (NR, dark grey, n = 2), the spermidine‐treated group (Spd) responders (G1, Green, n = 12) and Spd non‐responders (G2, Blue, n = 8). (D) Anti‐spike IgG intensity (ELISA) at day 0/baseline, 2, 13 and 37 weeks post‐spermidine (Spd) treatment for Spd responders (G1, green), Spd non‐responders (G2, blue) and placebo (grey), raw data (left panel) and Anti‐spike IgG fold change at 2 weeks, 13 weeks, and 37 weeks post‐spermidine compared to baseline (right panel). (E) ACE2 inhibition (%) log 2 fold change in placebo and both Spd groups across all timepoints compared to Day 0 as measured with the neutralisation antibody assay against the SARS‐CoV‐2 Wuhan variant. (F) Anti‐spike IgG from FluoroSpot for PBMC‐derived B cells at 0 and 2 weeks post spermidine (Spd) for Spd responders (G1, green), Spd non‐responders (G2, blue) and placebo (grey) raw data (left panel) and fold change at 2 weeks post spermidine (right panel). Exact p values are reported. Outliers were retained in all statistical analyses; in some plots, extreme values were omitted from display for clarity. Data are presented as Box plots or violin plots showing median, IQR, and 1.5 × IQR whiskers for box plots, with statistical comparisons using the two‐sided Wilcoxon signed‐rank test for B and E and rank‐sum test for A and C. Analyses were conducted in R 4.5.0; α = 0.05.
Article Snippet: Stimulated PBMCs were then added at 2 × 10 5 cells/well to FluoroSpot plates (Human IgA/IgG FluoroSpotFLEX kit, Mabtech, X‐06G05R‐1) coated with 10 μg/mL
Techniques: Inhibition, Enzyme-linked Immunosorbent Assay, Variant Assay, Derivative Assay
Journal: Biotechnology Journal
Article Title: An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice
doi: 10.1002/biot.70216
Figure Lengend Snippet: Construction, expression, and characterization of recombinant adenoviral vectors encoding the SARS‐CoV‐2 Spike protein. (A) Schematic representation of the adenoviral expression plasmid construction using Gateway LR recombination. The entry plasmid (pDONR223 SARS‐CoV‐2 S) containing attL1/attL2 recombination sites was recombined with the destination vector (pAd/CMV/V5‐DEST) containing attR1/attR2 sites using LR clonase enzyme mix. The resulting transfer plasmid (pAd5Spike) includes the full‐length Spike gene under a CMV promoter along with adenoviral vector backbone sequences. Simulation images were generated using SnapGene. (B) Agarose gel electrophoresis analysis of pAd5Spike plasmids. The left panel shows the simulated gel image, and the right panel displays actual gel electrophoresis of plasmids isolated from three independent bacterial colonies (lanes 1–3). MW: 1 kb Plus DNA Ladder (Thermo, SM0313). (C) Immunocytochemical analysis of SARS‐CoV‐2 Spike protein expression in HEK293T cells transfected with pAd5Spike. Cells transfected with pAd5Spike show strong brown immunostaining, indicating Spike expression, while control cells (transfected with PEI alone) show no signal. (D) CsCl density gradient ultracentrifugation of recombinant adenoviral particles. Two distinct bands are visible: the lower band represents genome‐containing Ad5Spike particles, and the upper band corresponds to empty viral capsids, indicating successful viral purification. (E) Immunofluorescence analysis of spike protein expression in HT1080 cells transduced with Ad5Spike at increasing multiplicities of infection (MOI: 10 2 –10 5 ). Cells were stained 72 h post‐transduction using an anti‐Spike antibody (green, Alexa Fluor 488). Nuclei were counterstained with DAPI (blue). Scale bars: 100 µm.
Article Snippet: Codon‐optimized cDNAs encoding the
Techniques: Expressing, Recombinant, Plasmid Preparation, Generated, Agarose Gel Electrophoresis, Nucleic Acid Electrophoresis, Isolation, Transfection, Immunostaining, Control, Purification, Immunofluorescence, Transduction, Infection, Staining
Journal: Biotechnology Journal
Article Title: An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice
doi: 10.1002/biot.70216
Figure Lengend Snippet: Humoral immune responses induced by Ad5Spike vaccination in BALB/c mice. Female BALB/c mice (6–8 weeks old, n = 5 per group per timepoint) were immunized intraperitoneally with the Ad5Spike vaccine vector at doses of 10 8 , 10 10 , or 10 1 2 viral particles. Control groups received PBS or an AdGFP vector. (A) Serum anti‐Spike IgG antibody titers were quantified by ELISA at days 30 and 90 post‐immunization. Data are presented as mean ± SD, with each data point representing an individual mouse. (B) SARS‐CoV‐2 Wuhan‐1 variant–specific neutralizing antibody titers were assessed in sera collected at days 30 and 90 using a pseudovirus‐based neutralization assay. Titers are expressed as ID 50 values (reciprocal serum dilution). Each dot represents an individual animal; box plots indicate the interquartile range with whiskers representing the 95% confidence interval. Normality was assessed using the Shapiro–Wilk test. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test, with comparisons made against the AdGFP vector–immunized control group. * p < 0.05, *** p < 0.001, **** p < 0.0001.
Article Snippet: Codon‐optimized cDNAs encoding the
Techniques: Plasmid Preparation, Control, Enzyme-linked Immunosorbent Assay, Variant Assay, Neutralization